Skip to main content

U.S. Denies Apple Tariff Relief on Mac Parts After It Commits to Assembling Its Computers in Texas

Apple was denied relief for tariffs on five Chinese-made components for the upcoming Mac Pro computer, even after the company announced it was keeping some assembly operations in the U.S.

The U.S. Trade Representative’s office refused to grant reprieve from 25% tariffs on the much-discussed optional wheels for Apple’s Mac Pro, a circuit board for managing input and output ports, power adapter, charging cable and a cooling system for the computer’s processor.

The decisions, posted Monday, come about a week after Apple announced it would make new Mac Pro computers in Austin, Texas after originally considering shifting production to China like its other products. The move followed an announcement this month that the U.S. trade office had agreed to Apple’s request for tariff waivers on 10 of 15 Chinese parts.

President Donald Trump on Monday linked on his Twitter account to a Fox Business story about Apple’s plans in Texas and praised the company for supporting U.S. jobs.

“Great news! @Apple announced that it is building its new Mac Pro in Texas. This means hundreds of American jobs in Austin and for suppliers across the Country. Congratulations to the Apple team and their workers!” the president tweeted Monday.

Economic Harm

Apple said it didn’t have any comment beyond last week’s announcement.

Exclusion decisions are based on whether a product is available only from China, is strategically important or related to Chinese industrial programs, and whether duties will “cause severe economic harm” to the company or U.S. interests.

In letters to Apple posted online, USTR said the five exclusion requests were denied because they “failed to show that the imposition of additional duties on the particular product would cause severe economic harm to you or other U.S. interests.”

In announcing that the Mac Pro would continue to be made in Texas, Apple applauded the Trump administration for its tariff relief on the other components, including the computer’s casing and accessories like the mouse and trackpad. The starting price for the Mac Pro is $5,999 and the optional wheels are expected to be an extra cost.

In its 15 requests for exclusions posted July 18, Apple said the devices or components are not related to Chinese industrial programs — and that “there are no other sources for this proprietary, Apple-designed component.”

No Relief

Trump had signaled that relief from tariffs would be rejected, saying in a July 26 tweet that “Apple will not be given Tariff waiver, or relief, for Mac Pro parts that are made in China. Make them in the USA, no Tariffs!” But the president later told reporters “we’ll work it out” and that “I think they’re going to announce they’re going to build a plant in Texas.”

Apple’s requests involved goods that are part of $200 billion in Chinese products hit with tariffs last September. Trump increased the duty on that batch to 25% from 10% in May. The rate is due to rise to 30% on Oct. 15, including on another $50 billion of goods also hit last year.

Products such as the Apple Watch, AirPods and iMac computers were hit by 15% tariffs earlier this month, while the iPhone, iPad and other major Apple products are set to be impacted later in December. Apple has maintained that its products are primarily designed in the U.S. and has grown its local investment since the trade war began brewing.

More must-read stories from Fortune:

—The cheapest mobile plans for your iPhone 11
How Russian PR firms plant stories for companies in U.K. news outlets, social media
—From premium speakers to privacy, Amazon has a plan to make Alexa sound even better
—Meet the women leading Netflix into the streaming wars
Why Apple is offering cheaper streaming and iPhones
Catch up with Data Sheet, Fortune’s daily digest on the business of tech.



from Fortune https://ift.tt/2mppsnO

Comments

Popular posts from this blog

Photo finish: Crashing sales force Olympus to sell iconic camera business

Sometimes, the vicissitudes of capitalism force companies to exit the businesses for which they’re best known. Olympus, once a leading light in the photography industry, is now joining that list. On Wednesday, the company said it planned to quit its 84-year-old camera business. The imaging giant, known for its once-pervasive digital cameras, agreed to sell off the declining unit by year’s end. Japan Industrial Partners, a private equity firm best known for buying Sony’s struggling Vaio computer line in 2014, agreed to purchase the business. Terms of the deal were not disclosed. A glance at Olympus’s financial statements provides all the rationale for the divestiture; as at rival manufacturers, camera sales have plummeted over the past decade. For the fiscal year ended March 31, Olympus’s camera unit declined 10% versus the year prior to  ¥43.6 billion, or $407 million. The unit’s sales have collapsed by three-quarters from a decade ago, when the company brought in ¥175 billion, or $

WHO says common steroids can slash death risk for the sickest coronavirus patients

Our mission to help you navigate the new normal is fueled by subscribers. To enjoy unlimited access to our journalism,  subscribe today . An old drug can learn new tricks during the coronavirus pandemic. That’s the main takeaway from the World Health Organization (WHO) in a new analysis of corticosteroids—a class of drugs which have existed for dozens of years and are far cheaper than new, experimental COVID treatments in development—suggesting that drugs like dexamethasone can slash the chances of COVID-19 related deaths by as much as 35% in the sickest patients. The WHO analysis of coronavirus drugs encompassed seven separate studies. And while an analysis of this sort—what’s called a “meta-analysis”—isn’t as rigorous as other types of trials like a randomized controlled study, the data are compelling. Corticosteroids have a very different action mechanism from many of the other coronavirus drugs in development. COVID-19 is a peculiar disease. Some who have been infected may be